status of compounded tirzepatide Compounded Tirzepatide

Prescription weight-management medications may be used (in combination with a reduced-calorie diet and increased physical activity) for people with one of the following conditions: A body mass index (BMI) of 30 or higher A BMI of 27 or higher with a weight-related condition, such as high blood pressure or type 2 diabetes GLP-1s and weight-management medications may also be prescribed for reasons outside of this list

Abdominal distension, early satiety, and gastroesophageal reflux symptoms may also develop as consequences of prolonged gastric retention

In fact, semaglutide is FDA-approved for weight loss under the brand name Wegovy

They tell me theyre hungry now, or theyve gained back weight. Medical spas, which may sell products made by compounding pharmacies, might not properly screen patients for suitability, says Andrew Kraftson, an endocrinologist and director of the weight navigation program at the University of Michigan